D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

- ZEVASKYN is the only FDA-approved therapy to treat RDEB wounds with a single application - ...

4FRONT-1 Phase 3 expected data readout accelerated from H2 2027 to H1 2027 4FRONT-2 Phase 3 trial initiated ahead of schedule Streamlined late-stage clinical and pre-commercial organization aligns ...

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

AI image generators are straight-up magic in 2025, turning text prompts into jaw-dropping visuals in seconds. Whether you’re ...

The new Safety Trekr AI platform delivers fast, trusted safety guidance using artificial intelligence and verified content ...

Ivermectin administered to the whole population significantly reduces malaria transmission, offering new hope in the fight against the disease.

Researchers led by UC Davis Health scientist Sanchita Bhatnagar have developed a promising gene therapy that could treat Rett ...

At Safety 2025, keynote speaker Shasta Nelson told safety professionals that positivity, consistency, and vulnerability are ...

The latest edition of our weekly Dezeen Agenda newsletter features a flat-pack cooking stove for displaced people. Subscribe ...

The report offers an in-depth analysis of vectorized antibodies via in vivo expression of DNA/RNA. It explores stakeholders, R&D pipelines, drug compositions, and business deals as of June 2025, ...

A survey in Australia and New Zealand has found food poisoning was the most important food safety issue for consumers in 2024. Food Standards Australia New Zealand’s (FSANZ) Consumer Insights ...